Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06230978 · ClinicalTrials.gov registry record · NA
Evaluation of a Habit-based Work-up to Support Medication Adherence
A NA study, sponsored by University of Iowa.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT06230978: Completed NA study, sponsored by University of Iowa.
NCT06230978 is a NA study that has completed, run by University of Iowa. The registered enrollment target is 33 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06230978, a NA study, has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to test the impact of a medication-taking habit worksheet and discussion with a pharmacist in patients who are prescribed a new chronic medication for cardiovascular disease or depression. The main questions it aims to answer are: * What is the feasibility and acceptability of the workup from the perspective of the patients and the clinic? * What is the impact of the intervention on the formation of medication-taking habits compared to a comparison group who receive standard pharmacist counseling? * What is the difference in medication adherence beliefs and behaviors for the group receiving the habit workup compared to those receiving standard counseling?
Primary Outcome
Five-items from the medication Adherence Report scale assessed using 5-point Likert scale. Possible range 5-25 (higher values associated with greater medication adherence)
Interventions
- BEHAVIORAL Habit workup
- BEHAVIORAL Standard Medication Counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2024-04-01 |
| Est. Completion | 2025-02-28 |
| Phase | NA |
What the finished NCT06230978 record still lists
NCT06230978 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Habit workup is the first listed.
NCT06230978 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06230978 about?
NCT06230978 is a clinical study titled "Evaluation of a Habit-based Work-up to Support Medication Adherence". The goal of this clinical trial is to test the impact of a medication-taking habit worksheet and discussion with a pharmacist in patients who are prescribed a new chronic medication for cardiovascular disease or depression. The main questions it aims to answer are: * What is the feasibility and acc...
What is the current status of trial NCT06230978?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2024-04-01. Estimated completion is 2025-02-28.
What interventions are being tested in trial NCT06230978?
The interventions under investigation include: Habit workup (BEHAVIORAL), Standard Medication Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT06230978?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06230978's enrollment target sits among peer trials
33 1574th of 2000 higher than 423 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI